These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10929699)

  • 1. Miglitol and hepatotoxicity in type 2 diabetes mellitus.
    Carlson RF
    Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reducing postprandial glucose levels. Glucosidase antagonists].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
    [No Abstract]   [Full Text] [Related]  

  • 3. Miglitol for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1999 May; 41(1053):49-50. PubMed ID: 10368700
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
    Fehmann HC
    MMW Fortschr Med; 2000 May; 142(21):55. PubMed ID: 10872296
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
    Dimitriadis G; Raptis S
    Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of type 2 diabetes: insulin sensitizers improve results].
    Stadler HJ
    Pflege Z; 1999 Nov; 52(11):772-5. PubMed ID: 10788929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S; Turco S; Guarino G; Oliviero B; Rustici A; Torella R
    Ann Ital Med Int; 1999; 14(1):7-14. PubMed ID: 10528419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA
    Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 2 diabetes: glycemic targets and oral therapies for older patients.
    Lardinois CK
    Geriatrics; 1998 Nov; 53(11):22-3, 27-8, 33-4 passim. PubMed ID: 9824974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Sakamoto N; Tajima N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitors of alpha-glucosidase].
    Toeller M
    Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risk of complications in the diabetic patient. Postprandial blood glucose peaks as deciding factor].
    MMW Fortschr Med; 2000 Jul; 142(26-27):54-5. PubMed ID: 10929491
    [No Abstract]   [Full Text] [Related]  

  • 13. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.
    Scott LJ; Spencer CM
    Drugs; 2000 Mar; 59(3):521-49. PubMed ID: 10776834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
    Kuritzky L; Samraj G; Quillen DM
    Hosp Pract (1995); 1999 Sep; 34(10):43-6. PubMed ID: 10901748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
    Kellerer M; Jakob S; Linn T; Haslbeck M
    MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.
    Mitrakou A; Tountas N; Raptis AE; Bauer RJ; Schulz H; Raptis SA
    Diabet Med; 1998 Aug; 15(8):657-60. PubMed ID: 9702468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
    Scheen AJ
    Drugs; 2003; 63(10):933-51. PubMed ID: 12699398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus.
    Sels JP; Kingma PJ; Wolffenbuttel BH; Menheere PP; Branolte JH; Nieuwenhuijzen Kruseman AC
    Neth J Med; 1994 Jun; 44(6):198-201. PubMed ID: 8052342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.